Mackay Shields LLC Sarepta Therapeutics, Inc. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $658 Million - $936 Million	6,171,009 Added 28038.57%	6,193,018 $11.2 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $2.14 Million - $3.27 Million	22,009 New	22,009 $2.4 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $2.17 Million - $3.04 Million	-18,794 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$71.74 - $153.69 $150,654 - $322,749	-2,100 Reduced 10.05%	18,794 $2.48 Million
Q1 2018 May 03, 2018	BUY	$54.02 - $82.27 $1.13 Million - $1.72 Million	20,894 New	20,894 $1.55 Million

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.